NCT02221648View on ClinicalTrials.gov

Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain

PHASE2TerminatedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Lower Back Pain
Interventions
DRUG

Placebo

Subjects will be randomization to receive either the study drug or the placebo group.

DRUG

AbobotulinumtoxinA Treatment

Subjects receive intervention injections with the study drug arbobotulinumtoxinA.

Trial Locations (1)

06520

Yale Medical Group, New Haven

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

Yale University

OTHER

NCT02221648 - Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back Pain | Biotech Hunter | Biotech Hunter